Article
Identification of differential polypharmacology between the PARP inhibitor rucaparib and…
bioRxiv: the preprint server for biology · 2022 · Huabin Hu, author Carme Serra, author Amadeu Llebaria, author Albert A. Antolin, author
Key facts
| Title | Identification of differential polypharmacology between the PARP inhibitor rucaparib and its major metabolite |
|---|---|
| First author | Huabin Hu, author Carme Serra, author Amadeu Llebaria, author Albert A. Antolin, author |
| Journal | bioRxiv : the preprint server for biology |
| Published | Nov 25, 2022 |
| DOI | 10.1101/2022.11.22.517505 |
| Devices mentioned | 204735 |
At a glance
- 1–9 FDA submissions mentioned
- None Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1